Otsuka Pharmaceutical Co.,Ltd.

Lĩnh vực: Công nghiệp nặng



  • Shinagawa Grand Central Tower
    2-16-4 Konan, Minato-ku, Tokyo 108-8242 (Tokyo Headquarter)
  •  03-6717-1400
  •  03-6717-1499

Lịch sử phát triển

1921 Establishment of Otsuka Seiyaku Kogyo-bu (Otsuka Pharmaceutical) by Busaburo Otsuka

1964 Establishment of Otsuka Pharmaceutical Co., Ltd.

1970 Completion of Tokushima Factory

1971 Completion of Tokushima Factory

1973 Establishment of Thai Otsuka Pharmaceutical Co., Ltd.
Establishment of Palo Alto office in the U.S.

1974 Establishment of P.T. Otsuka Indonesia
Establishment of Taiwan Otsuka Pharmaceutical Co., Ltd.

1977 Establishment of Arab Otsuka Pharmaceutical Co., S.A.E. (currently Egypt Otsuka Pharmaceutical Co., S.A.E.)

1981 Establishment of first Japan/China joint venture, China Otsuka Pharmaceutical Co., Ltd.

1982 Establishment of JE-IL Otsuka Pharmaceutical Co., Ltd. (currently Korea Otsuka Pharmaceutical Co., Ltd.) in Korea
Establishment of Frankfurt Research office in Germany, the first Otsuka research center in Europe

1985 Establishment of Maryland Research Laboratories in the U.S.

1987 Establishment of Otsuka Pakistan Ltd.
Investment in Dong-A Foods Co., Ltd (currently Dong-A Otsuka Co., Ltd.) in Korea

1988 Investment in Pharmavite Corporation (Pharmative LLC) in the U.S.
OPC Invests in P.T.Merapi Utama Pharma
P.T.Otsuka Jaya Indah in Indonesia joins the Otsuka Group.

1989 Establishment of Otsuka America, Inc., as headquarters for U.S. operations
Establishment of Otsuka America Pharmaceutical, Inc. for research, development, and sales of pharmaceuticals

1990 Investment in Crystal Geyser Water Company in the U.S.

1993 Establishment of Guangdong Otsuka Pharmaceutical Co., Ltd. in China

1995 OPC Invests in P.T.Widatra Bhakti in Indonesia

1996 Establishment of King Car Otsuka Co., Ltd. in Taiwan

1998 Establishment of Otsuka Pharmaceutical Europe Ltd. as headquarters for European operations
Investment in Cambridge Isotope Laboratories, Inc. in the U.S.

1999 Partnership with Pharmacia & UpJohn Co. for co-promotion of PLETAL in the U.S.

2000 Approval for marketing of PLETAL in the U.K. by Otsuka Pharmaceutical Europe Ltd.

2002 Launch of atypical antipsychotic drug ABILIFY with Bristol-Myers Squibb Co. in the U.S.
Establishment of Sichuan Otsuka Pharmaceutical Co., Ltd. in China
Establishment of Tianjin Otsuka Beverage Co., Ltd. in China
Establishment of Otsuka OPV Co., Ltd. in Vietnam

2003 Establishment of Otsuka Beijing Research Institute in China
Establishment of Otsuka (China) Investment Co., Ltd. in China
Establishment of Zhejiang Otsuka Pharmaceutical Co., Ltd. in China

2004 Establishment of Otsuka Pharmaceutical France SAS
Establishment of Otsuka Sims (Guangdong) Beverage Co., Ltd. in China

2006 VV Food & Beverage Co., Ltd. launches SOYJOY in China.

2007 King Car Otsuka Co., Ltd. launches SOYJOY in Taiwan.
Pharmavite LLC launches SOYJOY in the U.S.
Otsuka Pharmaceutical Development & Commercialization Inc. established in the U.S.

2008 OPC invests in French Beverage manufacturer Alma S.A.
OPC acquires rights for new peptide vaccine from Onco Therapy Science, Inc
OPC invests in Czech Republic-based Interpharma Praha, a.s.
Establishment of Otsuka Shanghai Research Institute.
Otsuka Holdings Co., Ltd. Established

2009 Launch of oral vasopression V2-receptor antagonist SAMSCA in the U.S. and Europe
OPC acquires France based Nutrition & Sante SAS.

Các dự án / Sản phẩm / Dịch vụ chính

Abilify, Mucosta, Meptin, Pocari Sweat, SOYJOY, ULOS, etc.

Asian head Quarter: OIAA Division
  • 3-2-27 Otedori,
  • Chuo-ku,
  • Osaka, 540-0021
  •  06-6943-7722
  •  06-6941-1921

Các sản phẩm/dịch vụ chính

Major projects in Asia & India; Manufacture & Distribute Pharmaceutical & Nutraceutical products.